Twist Bioscience Corporation (TWST) Stock Analysis — Probabli.AI
AI-powered analysis for TWST (Twist Bioscience Corporation): probabilistic price forecasts, technical signals, peer comparison, institutional ownership, earnings history, and social sentiment. AI consensus: Bullish.
Last price: $47.49 · Market cap: $2.9B · AI consensus: Bullish
Twist Bioscience (TWST) operates at the forefront of synthetic biology and biotechnology. The company has shown remarkable revenue growth and strong market presence with innovations and strategic partnerships. While profitability remains a challenge, the use case for its products in gene therapy, synthetic biology, and advanced research sectors positions it as a promising leader for long-term…
Probabilistic 1-Year Outlook
- Bull 5500% · Neutral 3500% · Bear 1000%
- The analyst concensus indicates a 'BUY' rating, with mean and median targets slightly above the current price. The company's revenue growth, market position, and recent positive headlines suggest strong momentum in the…
5-Year Outlook
- Bull 6500% · Neutral 2500% · Bear 1000%
SWOT Highlights
- Strength: High revenue growth rate.
- Strength: Strategic collaborations in synthetic biology.
- Risk: Negative EPS estimates and profitability not yet realized.
- Risk: High competition in the biotech field.
Major Catalysts
- [object Object]
- [object Object]
- [object Object]
Analyst Coverage & Dividends
8 Wall Street analysts rate TWST a BUY with a mean price target of $48.75.
Analysis generated Mar 24, 2026 · Model: gpt-4o. Run a fresh analysis on probabli.xyz/stock/TWST.
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.